Riskpilot← Back to searchSign inGet full accessOxehealth AB
ABActiveOrg 5592757487Kammargatan 47Computer consultancy and computer facilities management activities · NACE 6220Est. 20202 employees
Revenue 2024
SEK 3,6M
-18% vs 2023
EBITDA margin
2.6%
-14% vs 2023
Equity ratio
94.2%
Financial strength
Net profit 2024
SEK 38K
-42% vs 2023
| Revenue | SEK 3,6M | -18% |
| EBITDA | SEK 93K | -14% |
| Net profit | SEK 38K | -42% |
| Total assets | SEK 329K | -98% |
| Equity | SEK 310K | +14% |
| Employees | 2 | — |
Legal name
Oxehealth AB
Org number
5592757487
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
9 oktober 2020
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska bedriva verksamhet inom IT-konsultationer och tjänster inom optiska sensorsystem och därmed förenlig verksamhet.
Address
Kammargatan 47
Email
danny.rose@oxehealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 5 612 | 6 741 | 4 339 | 3 574 |
| Staff expenses | — | — | — | — |
| EBITDA | 111 | 153 | 108 | 93 |
| Depreciation & amort. | −2 | −21 | −23 | −23 |
| EBIT | 109 | 132 | 85 | 70 |
| Net financials | — | — | — | −15 |
| Profit before tax | 109 | 133 | 85 | 55 |
| Tax | −28 | −32 | −20 | −17 |
| Net profit | 81 | 101 | 65 | 38 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 5 743 | 12 525 | 14 520 | 329 |
| Equity | 106 | 207 | 272 | 310 |
| Long-term debt | 3 818 | 9 722 | 13 507 | 0 |
| Short-term debt | 1 819 | 2 596 | 742 | 20 |
| Total debt | 5 637 | 12 318 | 14 249 | 20 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20212024
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20212024
Return on equity
12.3%
This company
18.4%
Market median
+33% vs market
20212024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20212024
Asset turnover
10.86×
This company
1.12×
Market median
+870% vs market
20212024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA Audit | Audit | 2024 |
SS Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2024 – 2025 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oxehealth AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Merle Adamson | Audit | 0 companies |
| Silvia Strauss | Authorized Recipient of Service | 0 companies |
| Hugh Lloyd -Jukes | Deputy Board Member | 0 companies |
| Thomas Michael Hatfield | Board of Directors | 0 companies |
| Katrin Engelmann | Deputy Board Member | 0 companies |
| Tarvo Silivask | Deputy Board Member | 0 companies |
| Danny Percival Rose | Deputy Board Member | 0 companies |
| Todd Michael Headrich | Board of Directors | 0 companies |